Invesco BulletShares 2026 Corporate Bond ETF (NASDAQ: BSCQ)

에 대한 최신 뉴스 Invesco BulletShares 2026 Corporate Bond ETF (NASDAQ:BSCQ)

Invesco BulletShares 2026 Corporate Bond ETF

PowerShares BulletShares 2026 Corporate Bond Portfolio

Claymore Exchange-Traded Fund Trust ETF

The Fund generally will invest at least 80% of its total assets in securities that comprise the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, Invesco Indexing LLC (the Index Provider) compiles and maintains the Underlying Index.

Invesco Government & Agency Portfolio, Institutional Class

WIIM

KRMN

Karman Holdings shares are trading higher after the company reported better-than-expected Q1 financial results.

CLBT

Cellebrite DI shares are trading lower after the company reported mixed Q1 financial results and cut its FY25 sales guidance with its midpoint below estimates. Also, the company issued Q2 sales guidance with its midpoint below estimates.

Arbutus Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABUS#NASDAQ">ABUS</a>) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.10) by 30 percent. This is a 30 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $1.76 million which missed the analyst consensus estimate of $1.78 million by 0.84 percent. This is a 15.14 percent increase over sales of $1.53 million the same period last year.

Earnings

Earnings Misses

News

ABUS

Arbutus Biopharma Q1 EPS $(0.13) Misses $(0.10) Estimate, Sales $1.76M Miss $1.78M Estimate

Needham analyst Gil Blum reiterates Absci (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>) with a Buy and maintains $9 price target.

Price Target

Reiteration

Analyst Ratings

ABSI

Needham Reiterates Buy on Absci, Maintains $9 Price Target

Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.05 by 220 percent. This is a 700 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $78.33 million which beat the analyst consensus estimate of $76.60 million by 2.26 percent. This is a 5.24 percent increase over sales of $74.43 million the same period last year.

Earnings Beats

NEXN

Nexxen International Q1 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $78.33M Beat $76.60M Estimate

Inozyme Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INZY#NASDAQ">INZY</a>) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.41) by 7.32 percent. This is a 15.79 percent decrease over losses of $(0.38) per share from the same period last year.

INZY

Inozyme Pharma Q1 EPS $(0.44) Misses $(0.41) Estimate

Pony AI Inc. ("Pony.ai" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>), a global leader in achieving large-scale commercialization of autonomous mobility, today announced that Dr. Jun Peng, Chairman of the Board, Co-founder, and CEO, and Dr. Tiancheng Lou, Co-founder and CTO, have each entered into voluntary extended lock-up agreements (the "Extended Lock-Ups"). These agreements cover all shares of the Company's share capital or securities convertible into, exchangeable, or exercisable for any shares of the Company's share capital directly or indirectly owned by the co-founders for a period of 540 days starting from May 25, 2025, the expiration date of the Company's initial public offering lock-up period.
The Extended Lock-Ups cover a total of 110,828 Class A ordinary shares and 81,088,770 Class B ordinary shares, representing approximately 22.9% of the Company's total issued and outstanding ordinary shares as of the date of this announcement.

PONY

Pony.ai Co-Founders Extend Lock-Up on Nearly 23% of Shares, Signaling Long-Term Commitment

Chardan Capital analyst Daniil Gataulin maintains MeiraGTx Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGTX#NASDAQ">MGTX</a>) with a Buy and lowers the price target from $38 to $35.

MGTX

Chardan Capital Maintains Buy on MeiraGTx Hldgs, Lowers Price Target to $35

Wedbush analyst Daniel Ives praised the upcoming &#8216;AI Revolution&#8217; in Saudi Arabia and the Middle East after the U.S.-Saudi Investment Forum on Tuesday, which saw a slew of announcements on the artificial intelligence front.
What Happened: The Jensen Huang-led chipmaker announced a new agreement to supply 18,000 GB300 <a href="https://www.benzinga.com/markets/25/05/45397196/jensen-huangs-wealth-surges-37-since-liberation-day-lows-as-nvidia-re-enters-3-trillion-market-cap-club-on-saudi-chip-pact">Blackwell chips</a> to Saudi-based AI startup Humain, backed by the nation's sovereign wealth fund.
Ives said in a series of X posts that &#8220;the AI Revolution is coming to the Saudi Kingdom and Riyadh will be a major buyer of AI chips, software, autonomous/robotics, datacenters over the next decade.&#8221;
He also added that this move will be bullish for firms like, Nvidia, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) and Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
&#8220;Bullish for Nvidia, Tesla, Palantir, Microsoft, Alphabet, Amazon. Just starting,&#8221; he added.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The theme was clear in Riyadh&#8230;the AI Revolution is coming to the Saudi Kingdom and Riyadh will be a major buyer of AI chips, software, autonomous/robotics, datacenters over the next decade. Bullish for Nvidia, Tesla, Palantir, Microsoft, Alphabet, Amazon. Just starting &#x1f3c6;&#x1f525;&#x1f402;
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1922591983027020045?ref_src=twsrc%5Etfw">May 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He added that this was a part of President Donald Trump&#8216;s administration&#8217;s &#8220;global game of high stakes poker&#8221;. He highlighted the curbs on China to acquire Nvidia&#8217;s chips and how the U.S. was steering toward giving Saudi Arabia to supply its next generation chips.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">It also speaks to this global game of high stakes poker being played by the Trump Admin as while China is getting blockades from Nvidia&#39;s older H20 chip slowing down the AI buildout in Beijing, on the contrary Saudi getting the best Nvidia next generation chips red carpet rollout <a href="https://t.co/ALaTBIozUX">https://t.co/ALaTBIozUX</a>
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1922604976020320432?ref_src=twsrc%5Etfw">May 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;This is all part of a regional focus in the Middle East building out datacenters and the AI Revolution which will start to vault UAE, Saudi, Qatar to the priority list for US tech companies. Adds major TAM to AI Revolution,&#8221; he said.
See Also: <a href="https://www.benzinga.com/general/market-summary/25/05/45399940/warren-buffett-shows-how-patience-pays-98-of-his-160-billion-wealth-came-after-turning-65-thanks-the-power-of-compound-interest">Warren Buffett Shows How Patience Pays: 98% Of His $160 Billion Wealth Came After Turning 65, Thanks The Power Of &#8216;Compound Interest&#8217;</a>
Why It Matters: Following a dip to $83 billion in the first week of April, shortly after the &#8220;Liberation Day&#8221; tariffs, Huang&#8217;s net worth has since experienced a <a href="https://www.benzinga.com/markets/25/05/45397196/jensen-huangs-wealth-surges-37-since-liberation-day-lows-as-nvidia-re-enters-3-trillion-market-cap-club-on-saudi-chip-pact">significant rebound</a>. By the end of Tuesday, it had surged by 37% from that low point, reaching just under $120 billion. &#8211;
Also, Nvidia's recent stock rally has driven the company back into the $3 trillion market cap club.
Meanwhile, Trump also <a href="https://www.benzinga.com/markets/equities/25/05/45398595/trump-praises-nvidia-ceo-jensen-huang-at-saudi-summit-tim-cook-isnt-here-but-you-are-controlling-99-of-the-chip-market-thats-not-easy-to-beat">appreciated Huang</a> at the Forum and said, "I see my friend is here, Jensen. [Apple Inc. CEO] Tim Cook isn't here, but you are.&#8221;
"What a job you've done. He's got 99% of the chip market. That's not easy to beat,&#8221; he added.
"Thank you for the investment. We are proud to have you in our country," Trump told Huang.
Price Action: Shares of Nvidia rose 5.63% on Tuesday and were up 2.61% on Wednesday in pre-market trading. However, the stock was down 6.06% on a year-to-date basis and up 42.22% over a year.
Benzinga Edge Stock Rankings shows that NVDA had a stronger price trend over the short, medium, and long term. Its momentum ranking was solid at 82.75th percentile, whereas its value ranking was poor at 6.65th percentile; the details of other metrics are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>. 
<figure class="wp-block-image size-large"><a href=" https://www.benzinga.com/quote/NVDA"><img loading="lazy" decoding="async" width="1024" height="143" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14071534/EDGE-NVDA-1024x143.png" alt="" class="wp-image-914799" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14071534/EDGE-NVDA-1024x143.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14071534/EDGE-NVDA-300x42.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14071534/EDGE-NVDA-768x108.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14071534/EDGE-NVDA.png 1228w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Wednesday. The SPY was up 0.16% to $587.79, while the QQQ advanced 0.33% to $517.30, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pr</a>o data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/market-summary/25/05/45399288/kevin-oleary-lauds-robinhoods-acquisition-of-wonderfi-will-transform-cross-border-trading-no-more-outrageous-bank-fees">Kevin O&#8217;Leary Lauds Robinhood&#8217;s Acquisition Of WonderFi Will &#8216;Transform Cross-Border Trading:&#8217; &#8216;No More Outrageous Bank Fees&#8217;</a></li>
</ul>
Image Via Shutterstock

Analyst Color

Equities

Government

Market Summary

Regulations

Broad U.S. Equity ETFs

Futures

Markets

Tech

ETFs

General

AMZN

GOOG

GOOGL

MSFT

PLTR

TSLA

'Bullish For Nvidia, Tesla, Palantir, Microsoft, Alphabet, Amazon:' AI 'Revolution Is Coming' To The Saudi Kingdom, Says Wedbush's Dan Ives

Owens Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>), a building products leader, today announced that its Board of Directors has approved a new share repurchase authorization for up to 12 million shares of the company's common stock. The action reaffirms the company's capital allocation strategy and reflects the success of its disciplined commercial and operational execution to deliver consistent and sustainable performance in dynamic market conditions.
This authorization is in addition to the previously announced share repurchase program in which approximately 5.7 million shares remained available for repurchase as of March 31, 2025.

Owens Corning Board Approves New Share Repurchase Authorization For Up To 12M Shares

Biotech

ABEO

Abeona Therapeutics And Lurie Children's Open Center For ZEVASKYNTM Gene Therapy To Treat Wounds Associated With Recessive Dystrophic Epidermolysis Bullosa

PDSB

PDS Biotechnology Q1 EPS $(0.21) Beats $(0.25) Estimate

Quoin Pharmaceuticals Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNRX#NASDAQ">QNRX</a>) (the "Company" or "Quoin"), a late clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announces positive initial clinical data from its ongoing Investigator Pediatric Peeling Skin Syndrome clinical study.
As the table below illustrates, after 12 weeks of treatment, clear evidence of skin healing in the area treated with QRX003 compared to baseline was observed.
<figure class="table"> 
<table>
<tbody>
<tr>
<td>End Point</td>
<td>Baseline</td>
<td>12 weeks (End of treatment period) &nbsp;</td>
</tr>
<tr>
<td>M-IASI&#x2A;</td>
<td>36</td>
<td>12 &nbsp;</td>
</tr>
<tr>
<td>IGA&#x2A;&#x2A;</td>
<td>4 (Severe)</td>
<td>2 (Mild) &nbsp;</td>
</tr>
<tr>
<td>CDQLI&#x2A;&#x2A;&#x2A;</td>
<td>19</td>
<td>11 &nbsp;</td>
</tr>
</tbody>
</table>
</figure>
 &#x2A;M-IASI: Modified Ichthyosis Area of Severity Index, a score used to assess the severity and extent of skin symptoms associated with ichthyosis. Lower scores indicate improvement. &#x2A;&#x2A;IGA: Investigator's Global Assessment, which uses descriptive categories (e.g., clear, mild, moderate, severe) to evaluate the overall severity of disease symptoms.
&#x2A;&#x2A;&#x2A; CDQLI: The Children's Dermatology Life Quality Index is a validated clinical tool designed for children aged 4-15 that is used to measure the impact of their skin disease on a child's quality of life in terms of symptoms, leisure activities, sleep, school, personal relationship and treatment. The scale for the CDQLI is 0-30.
QRX003 is being well tolerated by the patient and no adverse events have been reported. As a result of these positive initial results, the patient is expected to continue to be treated with QRX003 with a further clinical assessment by the investigator scheduled after 24 weeks of treatment.

QNRX

Quoin Reports Early Data for Rare Skin Disease Treatment With No Adverse Events

Arcos Dorados Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARCO#NYSE">ARCO</a>) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.13 by 46.15 percent. This is a 50 percent decrease over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $1.08 billion which beat the analyst consensus estimate of $1.05 billion by 2.14 percent. This is a 0.41 percent decrease over sales of $1.08 billion the same period last year.

ARCO

Arcos Dorados Holdings Q1 EPS $0.07 Misses $0.13 Estimate, Sales $1.08B Beat $1.05B Estimate

Multiple long-term LM survivors in those patients receiving multiple doses of REYOBIQ
RNA sequencing data show early tumor apoptosis and activation of innate immune responses
Updated ReSPECT data presented at the 2025 Nuclear Medicine and Neurooncology Conference
HOUSTON, May 14, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=NFvPtjrMT2cxlwT9EYDcpmv5A_g2fAoFWMszoLPF1HUlMZgqEZgs7ghCw8v2brzCKMAt2MDrj2u8CMIEd-zZJQXJ56OG7oRamFCSnxIqj-zJ7sfNwuIhnMRMhQA86p3F">Plus Therapeutics, Inc.</a> (Nasdaq:&nbsp;<a href="https://www.globenewswire.com/Tracker?data=khU81DaUZRrYBaFqq__KNV3OgsLR1WfvFvRFX5PV7tkIF_m7OhBi_1SKqUVn0eB5XQpGlcuRfQ4o3laDOgfmjg==">PSTV</a>) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announces the presentation of new data on its lead drug REYOBIQ&#x2122; (rhenium Re186 obisbemeda) during both an oral presentation and a poster presented at the Nuclear Medicine and Neurooncology Conference. The meeting was held May 9-10, 2025 in Vienna, Austria.

PSTV

Plus Therapeutics: REYOBIQ Shows Clinical Benefit And Safety In ReSPECT-LM Clinical Trial For Patients With Leptomeningeal Metastases

Needham analyst Gil Blum reiterates Fate Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATE#NASDAQ">FATE</a>) from Hold to Hold.

FATE

Needham Reiterates Hold on Fate Therapeuticsto Hold

American Eagle Outfitters shares are trading lower after the company guided Q1 revenue down and withdrew FY25 guidance.

Jefferies analyst Omar Nokta maintains Danaos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAC#NYSE">DAC</a>) with a Buy and raises the price target from $100 to $105.

Jefferies Maintains Buy on Danaos, Raises Price Target to $105

Jeff Bezos vaulted onto the Forbes billionaire list at 34 because he did one thing most rising Wall Street stars wouldn't risk.
What Happened: The Princeton-trained computer scientist, class of '86, left hedge-fund D.E. Shaw as a vice president in 1994 after spotting a report that "Web usage was growing at 2,300 percent per year." "I'd never seen or heard of anything that grew that fast," he <a href="https://www.princeton.edu/news/2010/05/30/2010-baccalaureate-remarks">later recalled</a> in a 2010 speech at Princeton.
Bezos, 30, drove from New York to Seattle, <a href="https://www.benzinga.com/general/education/23/07/33119760/amazon-was-founded-29-years-ago-today-if-you-invested-1-000-in-amazon-stock-at-ipo-in-1997-here">seeded the venture</a> with $10,000 of his cash and lined up $84,000 in interest-free loans. Working from a rented garage, he launched Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) on July 16, 1995. Within two months, the online bookstore was booking $20,000 a week in orders.
The company went public on May 15, 1997, at $18 a share. A year later, Amazon's soaring stock put Bezos on Forbes' rich list with a net worth of $1.6 billion.
See also: <a href="https://www.benzinga.com/tech/25/05/45397728/youtube-scores-nfl-first-chargers-game-in-brazil-to-stream-free-worldwide">YouTube Scores NFL First: Chargers Game In Brazil To Stream Free Worldwide</a>
What To Know: Bezos' instinct to leap first has paid compounding dividends. He was the world's <a href="https://www.benzinga.com/news/17/07/9834929/jeff-bezos-adds-worlds-richest-person-to-achievements-a-chart-of-his-career">wealthiest person</a> from 2017 to 2021, according to Forbes, before ceding the crown to Tesla and SpaceX CEO Elon Musk. Today, Bloomberg's Billionaire index pegs him at roughly $232 billion, ranking him No. 2 globally.
Bezos often frames the gamble as a "<a href="https://www.benzinga.com/news/24/07/39666069/jeff-bezos-described-his-unique-life-philosophy-which-follows-a-dorky-framework-revolving-regret-min">regret-minimization framework</a>" — a calculation that failing would sting less than never trying. Three decades later, Amazon commands a market value above $2.2 trillion and has made its founder one of history's richest entrepreneurs — all because he decided the surest path to wealth was walking away from a sure thing.
Photo Courtesy: Lev Radin on Shutterstock.com
Read next: <a href="https://www.benzinga.com/markets/equities/25/05/45397896/roger-federer-backed-on-holding-jumps-12-as-dtc-sales-soar-sneaker-price-hikes-coming-to-offset-tariffs-and-fuel-premium-growth">Roger Federer-Backed On Holding Jumps 12% As DTC Sales Soar —Sneaker Price Hikes Coming To Offset Tariffs And Fuel Premium Growth</a>

Startups

Jeff Bezos Became A Billionaire After Taking This Leap Of Faith: Would You Have The Stomach For His 'Regret-Minimization' Strategy?

Everus Construction Group shares are trading higher after the company reported better-than-expected Q1 financial results.

Comments

Invesco BulletShares 2026 Corporate Bond ETF

뉴스

에 대한 최신 뉴스 Invesco BulletShares 2026 Corporate Bond ETF (NASDAQ:BSCQ)

뉴스

파트너 / 기고자

벤징가 글로벌